Cytokine gene expression in the marrow stromal cells of patients with giant cell arteritis
- PMID: 9844760
Cytokine gene expression in the marrow stromal cells of patients with giant cell arteritis
Abstract
Objective: Anemia of chronic disease is a common feature of giant cell arteritis (GCA). It has been shown that constitutive hematopoiesis is regulated in the bone marrow microenvironment by direct cell-to-cell contact between hematopoietic progenitor cells and marrow stromal cells. Since cytokines are of crucial significance in this process, we decided to examine the role of stem cell factor (SCF), granulocyte macrophage colony stimulating factor (GM-CSF), interleukin 3 (IL-3), granulocyte colony stimulating factor (G-CSF), and interleukin 1 alpha (IL-1 alpha), known for their stimulatory effects on in vitro hematopoiesis; and transforming growth factor beta (TGF beta), interferon gamma (IFN gamma) and tumor necrosis factor alpha (TNF-alpha), known for their inhibitory effect, in the anemia of GCA.
Methods: The expression of these cytokines was examined in the marrow stromal cells from 6 GCA patients with anemia of chronic disease and in 6 healthy individuals by the reverse transcription mediated polymerase chain reaction (RT-PCR).
Results: Consistent constitutive gene expression was detected in the marrow stromal cells of all control samples for SCF, GM-CSF, IL-1 alpha, TGF beta and TNF-alpha, while only 2/6 expressed IFN gamma. None of the controls expressed either IL-3 or G-CSF. In all GCA patients SCF, TGF beta and TNF-alpha were expressed, but the level of expression was reduced compared to the control group. IL-1 alpha was expressed in 3/6 patients, and IFN gamma in 2/6. More importantly, GM-CSF expression was not detected in any patient, in marked contrast with the controls.
Conclusion: The combination of the defective expression of SCF and GM-CSF, cytokines with a known stimulatory effect on in vitro hematopoiesis, may contribute to the pathogenesis of anemia in GCA.
Similar articles
-
Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment.J Hematother Stem Cell Res. 2001 Feb;10(1):125-40. doi: 10.1089/152581601750098372. J Hematother Stem Cell Res. 2001. PMID: 11276366
-
Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals.Blood. 1995 Apr 15;85(8):2038-44. Blood. 1995. PMID: 7718876
-
Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells.Cytokine. 2000 May;12(5):522-5. doi: 10.1006/cyto.1999.0580. Cytokine. 2000. PMID: 10857771
-
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review.
-
Hematopoietic growth factors and marrow stroma in aplastic anemia.Int J Hematol. 1998 Jul;68(1):19-28. doi: 10.1016/s0925-5710(98)00028-0. Int J Hematol. 1998. PMID: 9713165 Review.
Cited by
-
Glucose metabolism controls disease-specific signatures of macrophage effector functions.JCI Insight. 2018 Oct 18;3(20):e123047. doi: 10.1172/jci.insight.123047. JCI Insight. 2018. PMID: 30333306 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical